USD 17.1
↑ 0.35 (2.09%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| PEAK | -8.8 | -2.9 | 2.1 | -13.6 | -6.9 | -22.2 | -46.1 | -45.2 | -51.6 | 253.3 |
| S&P 500 | -0.3 | -0.1 | 1.9 | 9.4 | 13.8 | 32.8 | 27.5 | 92.8 | 192.7 | 33707.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | PEAK |
| name | Healthpeak Properties, Inc. |
| price | 17.1 |
| changes percentage | 2.0896 |
| change | 0.35 |
| day low | 16.51 |
| day high | 17.14 |
| year high | 22.38 |
| year low | 15.24 |
| market cap | 9356658163 |
| price avg 50 | 18.1512 |
| price avg 200 | 18.9437 |
| exchange | NYSE |
| volume | 9979122 |
| avg volume | 7594125 |
| open | 16.74 |
| previous close | 16.75 |
| eps | 0.55 |
| pe | 31.090909 |
| earnings announcement | 2024-02-05T00:00:00.000+0000 |
| shares outstanding | 547172992 |
| timestamp | 2024-03-01 21:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001574540 | |||
| revenue | 2181003000 | 526635000 | 314.14 |
| gross profit | 1278943000 | 355535000 | 259.72 |
| gross profit ratio | 0.59 | 0.68 | -13.14 |
| research and development expenses | 0.14 | 0.25 | -41.31 |
| operating expenses | 845033000 | 229850000 | 267.65 |
| interest income | 0 | 72234000 | -100.00 |
| interest expense | 200331000 | 72234000 | 177.34 |
| ebitda | 1189412000 | 314536000 | 278.15 |
| ebitdaratio | 0.55 | 0.6 | -8.60 |
| operating income | 360802000 | 124895000 | 188.88 |
| operating income ratio | 0.17 | 0.24 | -30.24 |
| net income | 306009000 | 37802000 | 709.50 |
| net income ratio | 0.14 | 0.07 | 95.47 |
| eps | 0.56 | 0.07 | 697.72 |
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001574540 | |||
| revenue | 700397000 | 695504000 | 0.70 |
| gross profit | 140099000 | 138179000 | 1.39 |
| gross profit ratio | 0.2 | 0.2 | 0.68 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | -23216000 | 310216000 | -107.48 |
| interest income | 14301000 | 7832000 | 82.60 |
| interest expense | 74105000 | 74910000 | -1.07 |
| ebitda | 396902000 | 395512000 | 0.35 |
| ebitdaratio | 0.57 | 0.57 | -0.35 |
| operating income | 116883000 | 112014000 | 4.35 |
| operating income ratio | 0.17 | 0.16 | 3.62 |
| net income | 85675000 | 146047000 | -41.34 |
| net income ratio | 0.12 | 0.21 | -41.75 |
| eps | 0.12 | 0.21 | -42.86 |
Revenue Growth: revenue increased to 700 million in 2024Q3 from 696 million in 2024Q2 representing a change of 0.7%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 140 million in 2024Q3 from 138 million in 2024Q2 representing a change of 1.39%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to -23 million in 2024Q3 from 310 million in 2024Q2 representing a change of -107.48%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 397 million in 2024Q3 from 396 million in 2024Q2 representing a change of 0.35%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to 117 million in 2024Q3 from 112 million in 2024Q2 representing a change of 4.35%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to 86 million in 2024Q3 from 146 million in 2024Q2 representing a change of -41.34%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.12 in 2024Q3 from 0.12 in 2024Q2 representing a change of -42.86%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001574540 | |||
| total assets | 15698850000 | 5096877000 | 208.01 |
| total liabilities | 8773980000 | 2099768000 | 317.85 |
| total equity | 6924870000 | 2997109000 | 131.05 |
| cash and cash equivalents | 117635000 | 7730000 | 1421.80 |
| short term investments | 21359000 | 2045000 | 944.45 |
| long term investments | 782853000 | 77716000 | 907.33 |
| total current assets | 561279000 | 124206000 | 351.89 |
| total non current assets | 15137571000 | 4972671000 | 204.42 |
| total current liabilities | 1377925000 | 340587000 | 304.57 |
| total non current liabilities | 7396055000 | 1759181000 | 320.43 |
| common stock | 547156000 | 2333000 | 23352.89 |
| retained earnings | -1061293000 | -881672000 | -20.37 |
| total debt | 7083042000 | 1923128000 | 268.31 |
Total Assets: Total Assets increased to 15,699 million in 2023 from 5,097 million in 2022 representing a change of 208.01%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 6,925 million in 2023 from 2,997 million in 2022 representing a change of 131.05%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 118 million in 2023 from 8 million in 2022 representing a change of 1421.8%. This indicates an increase in available liquid assets.
Short Term Investments: Short Term Investments increased to 21 million in 2023 from 2 million in 2022 representing a change of 944.45%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 561 million in 2023 from 124 million in 2022 representing a change of 351.89%. This indicates a better liquidity position.
Common Stock: Common Stock increased to 547 in 2023 from 2 in 2022 representing a change of 23352.89%. This indicates an increase in ownership interest.
Total Liabilities: Total Liabilities increased to 8,774 million in 2023 from 2,100 million in 2022 representing a change of 317.85%. This indicates an increase in overall liabilities.
Total Current Liabilities: Total Current Liabilities increased to 1,378 million in 2023 from 341 million in 2022 representing a change of 304.57%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -1,061 million in 2023 from -882 million in 2022 representing a change of -20.37%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 7,083 million in 2023 from 1,923 million in 2022 representing a change of 268.31%. This indicates an increase in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001574540 | |||
| total assets | 19969766000 | 20179708000 | -1.04 |
| total liabilities | 10747763000 | 10760937000 | -0.12 |
| total equity | 9222003000 | 9418771000 | -2.09 |
| cash and cash equivalents | 242045000 | 159295000 | 51.95 |
| short term investments | 0 | 50304000 | -100.00 |
| long term investments | 0 | 927204000 | -100.00 |
| total current assets | 0 | 494431000 | -100.00 |
| total non current assets | 0 | 19685277000 | -100.00 |
| total current liabilities | 0 | 1642071000 | -100.00 |
| total non current liabilities | 10747763000 | 9118866000 | 17.86 |
| common stock | 699405000 | 700317000 | -0.13 |
| retained earnings | -4968819000 | -4844683000 | -2.56 |
| total debt | 8583377000 | 9143866000 | -6.13 |
Total Assets: Total Assets decreased to 19,970 million in 2024Q3 from 20,180 million in 2024Q2 representing a change of -1.04%. Suggesting a decrease in asset holdings.
Total Equity: Total Equity decreased to 9,222 million in 2024Q3 from 9,419 million in 2024Q2 representing a change of -2.09%. This indicates a decrease in shareholders' equity.
Short Term Investments: Short Term Investments decreased to 0 million in 2024Q3 from 50 million in 2024Q2 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 0 million in 2024Q3 from 494 million in 2024Q2 representing a change of -100.0%. This indicates a worsen liquidity position.
Common Stock: Common Stock decreased to 699 in 2024Q3 from 700 in 2024Q2 representing a change of -0.13%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to -4,969 million in 2024Q3 from -4,845 million in 2024Q2 representing a change of -2.56%. This indicates an accumulated losses.
Total Liabilities: Total Liabilities decreased to 10,748 million in 2024Q3 from 10,761 million in 2024Q2 representing a change of -0.12%. This indicates a decrease in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 242 million in 2024Q3 from 159 million in 2024Q2 representing a change of 51.95%. This indicates an increase in available liquid assets.
Total Current Liabilities: Total Current Liabilities decreased to 0 million in 2024Q3 from 1,642 million in 2024Q2 representing a change of -100.0%. This indicates a lower short-term debt burden.
Total Debt: Total Debt decreased to 8,583 million in 2024Q3 from 9,144 million in 2024Q2 representing a change of -6.13%. This indicates a reduction in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001574540 | |||
| net change in cash | 42189000 | -2146000 | 2065.94 |
| operating cash flow | 956242000 | 258400000 | 270.06 |
| free cash flow | 842646000 | 218531000 | 285.60 |
| capital expenditure | -113596000 | -39869000 | -184.92 |
| depreciation and amortization | 749901000 | 189641000 | 295.43 |
| deferred income tax | -14605000 | -6001000 | -143.38 |
| stock based compensation | 14480000 | 26456000 | -45.27 |
| accounts payables | 3973000 | -2260000 | 275.80 |
| inventory | 104511000 | 0 | NaN |
| acquisitions net | -88391000 | -13587000 | -550.56 |
| investments in property plant and equipment | -113596000 | -39869000 | -184.92 |
| net cash used for investing activites | -576754000 | -38472000 | -1399.15 |
| debt repayment | 378083000 | 324583000 | 16.48 |
| common stock issued | 278000 | 308100000 | -99.91 |
| common stock repurchased | -6524000 | -67838000 | 90.38 |
| dividends paid | -657021000 | -649364000 | -1.18 |
| net cash used provided by financing activities | -337788000 | -222074000 | -52.11 |
| cash at end of period | 169023000 | 7730000 | 2086.58 |
| accounts receivables | -21566000 | -7652000 | -181.83 |
| cash at beginning of period | 126834000 | 9876000 | 1184.26 |
Net Change in Cash: Net Change in Cash increased to 42 million in 2023 from -2 million in 2022 representing a change of 2065.94%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 956 million in 2023 from 258 million in 2022 representing a change of 270.06%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 843 million in 2023 from 219 million in 2022 representing a change of 285.6%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -114 million in 2023 from -40 million in 2022 representing a change of -184.92%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 14 million in 2023 from 26 million in 2022 representing a change of -45.27%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Receivables: Accounts Receivables decreased to -22 million in 2023 from -8 million in 2022 representing a change of -181.83%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Accounts Payables: The absolute value of Accounts Payables increased to 4 million in 2023 from 2 million in 2022 representing a change of 275.8%. This indicates that the company has increased its outstanding obligations to its suppliers.
Dividends Paid: Dividends Paid decreased to -657 million in 2023 from -649 million in 2022 representing a change of -1.18%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
| 2024Q2 | 2024Q1 | Q/Q change % | |
|---|---|---|---|
| 0001574540 | |||
| operating cash flow | 324666000 | 159855000 | 103.10 |
| free cash flow | 288948000 | 142338000 | 103.00 |
| capital expenditure | -35718000 | -17517000 | -103.90 |
| depreciation and amortization | 283498000 | 219219000 | 29.32 |
| deferred income tax | 1060000 | 10006000 | -89.41 |
| stock based compensation | 4814000 | 19589000 | -75.42 |
| accounts receivables | 21505000 | -2171000 | 1090.56 |
| accounts payables | 5187000 | 420000 | 1135.00 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 2000 | 10000 | -80.00 |
| investments in property plant and equipment | -35718000 | -17517000 | -103.90 |
| net cash used for investing activites | 179063000 | -105062000 | 270.44 |
| debt repayment | -159102000 | 212139000 | -175.00 |
| common stock issued | 80000 | 94000 | -14.89 |
| common stock repurchased | -68234000 | -101995000 | 33.10 |
| dividends paid | -210943000 | -164200000 | -28.47 |
| net cash used provided by financing activities | -501592000 | -66658000 | -652.49 |
| net change in cash | 2137000 | -11865000 | 118.01 |
| cash at end of period | 159295000 | 157158000 | 1.36 |
| cash at beginning of period | 157158000 | 169023000 | -7.02 |
Net Change in Cash: Net Change in Cash increased to 2 million in 2024Q2 from -12 million in 2024Q1 representing a change of 118.01%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 325 million in 2024Q2 from 160 million in 2024Q1 representing a change of 103.1%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 289 million in 2024Q2 from 142 million in 2024Q1 representing a change of 103.0%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -36 million in 2024Q2 from -18 million in 2024Q1 representing a change of -103.9%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 5 million in 2024Q2 from 20 million in 2024Q1 representing a change of -75.42%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 5 million in 2024Q2 from 0 million in 2024Q1 representing a change of 1135.0%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 22 in 2024Q2 from -2 million in 2024Q1 representing a change of 1090.56%. This suggests that the company is less capable of collecting payments from its customers.
Dividends Paid: Dividends Paid decreased to -211 million in 2024Q2 from -164 million in 2024Q1 representing a change of -28.47%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 3.99 | 0.98 | 307.93 |
| net income per share | 0.56 | 0.07 | 697.37 |
| operating cash flow per share | 1.75 | 0.48 | 264.52 |
| free cash flow per share | 1.54 | 0.41 | 279.82 |
| cash per share | 0.25 | 0.02 | 1300.62 |
| book value per share | 12.66 | 5.56 | 127.59 |
| tangible book value per share | 12.09 | 4.62 | 161.33 |
| shareholders equity per share | 11.61 | 5.33 | 117.98 |
| interest debt per share | 14.24 | 12.36 | 15.21 |
| market cap | 10830733927.2 | 13507943786.02 | -19.82 |
| enterprise value | 17796140927.2 | 15423341786.02 | 15.38 |
| pe ratio | 35.39 | 357.33 | -90.10 |
| price to sales ratio | 4.97 | 25.65 | -80.64 |
| pocfratio | 11.33 | 52.28 | -78.33 |
| pfcf ratio | 12.85 | 61.81 | -79.21 |
| pb ratio | 1.71 | 4.71 | -63.77 |
| ptb ratio | 1.71 | 4.71 | -63.77 |
| ev to sales | 8.16 | 29.29 | -72.14 |
| enterprise value over ebitda | 14.96 | 49.04 | -69.49 |
| ev to operating cash flow | 18.61 | 59.69 | -68.82 |
| ev to free cash flow | 21.12 | 70.58 | -70.08 |
| earnings yield | 0.03 | 0.0 | 909.60 |
| free cash flow yield | 0.08 | 0.02 | 380.91 |
| debt to equity | 1.2 | 2.3 | -47.94 |
| debt to assets | 0.48 | 1.29 | -62.60 |
| net debt to ebitda | 5.86 | 6.09 | -3.83 |
| current ratio | 0.41 | 0.36 | 11.70 |
| interest coverage | 1.8 | 1.73 | 4.16 |
| income quality | 2.86 | 2.35 | 21.64 |
| dividend yield | 0.06 | 0.05 | 26.19 |
| payout ratio | 2.15 | 17.18 | -87.50 |
| sales general and administrative to revenue | 0.04 | 0.08 | -42.87 |
| research and ddevelopement to revenue | 0.0 | 0.0 | -85.83 |
| intangibles to total assets | 0.02 | 0.1 | -79.82 |
| capex to operating cash flow | 0.12 | 0.15 | -23.01 |
| capex to revenue | 0.05 | 0.08 | -31.20 |
| capex to depreciation | 0.15 | 0.21 | -27.95 |
| stock based compensation to revenue | 0.01 | 0.05 | -86.78 |
| graham number | 12.09 | 2.9 | 316.90 |
| roic | 0.03 | 0.0 | 487.93 |
| return on tangible assets | 0.02 | 0.01 | 141.60 |
| graham net net | -14.85 | -3.29 | -350.75 |
| working capital | -816646000 | -216381000 | -277.41 |
| tangible asset value | 6610714000 | 2491774000 | 165.30 |
| net current asset value | -8212701000 | -1975562000 | -315.71 |
| invested capital | -262335000 | 520179000 | -150.43 |
| average receivables | 351269000 | 446385000 | -21.31 |
| average payables | 252927000 | 246617000 | 2.56 |
| average inventory | 300046500 | -5305000 | 5755.92 |
| days sales outstanding | 45.9 | 296.82 | -84.54 |
| days payables outstanding | 97.22 | 566.58 | -82.84 |
| days of inventory on hand | 247.9 | -26.82 | 1024.20 |
| receivables turnover | 7.95 | 1.23 | 546.67 |
| payables turnover | 3.75 | 0.64 | 482.81 |
| inventory turnover | 1.47 | -13.61 | 110.82 |
| roe | 0.05 | 0.01 | 265.81 |
| capex per share | 0.21 | 0.07 | 180.65 |
ROE: Return on Equity (ROE) increased to 0.05 on 2023-12-31 from 0.01 on 2022-12-31, representing a change of 265.81%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 35.39 on 2023-12-31 from 357.33 on 2022-12-31, representing a change of -90.10%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 0.41 on 2023-12-31 from 0.36 on 2022-12-31, representing a change of 11.70%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.
Debt-to-Equity Ratio:
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| PEAK | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 1.0 | 0.99 | 1.22 |
| net income per share | 0.12 | 0.21 | -41.04 |
| operating cash flow per share | None | 0.46 | NaN |
| free cash flow per share | None | 0.41 | NaN |
| cash per share | 0.35 | 0.3 | 16.07 |
| book value per share | 13.19 | 13.4 | -1.59 |
| tangible book value per share | 11.9 | 11.87 | 0.28 |
| shareholders equity per share | 12.24 | 12.46 | -1.72 |
| interest debt per share | 12.38 | 12.35 | 0.27 |
| market cap | 15994111630 | 13686012131.88 | 16.86 |
| enterprise value | 24335443630 | 22670583131.88 | 7.34 |
| pe ratio | 46.67 | 23.43 | 99.21 |
| price to sales ratio | 22.84 | 19.68 | 16.05 |
| pocfratio | 0 | 42.15 | -100.00 |
| pfcf ratio | 0 | 47.36 | -100.00 |
| pb ratio | 1.87 | 1.56 | 19.52 |
| ptb ratio | 1.87 | 1.56 | 19.52 |
| ev to sales | 34.75 | 32.6 | 6.59 |
| enterprise value over ebitda | 61.31 | 57.32 | 6.97 |
| ev to operating cash flow | 0 | 69.83 | -100.00 |
| ev to free cash flow | 0 | 78.46 | -100.00 |
| earnings yield | 0.01 | 0.01 | -49.80 |
| free cash flow yield | None | 0.02 | NaN |
| debt to equity | 1.0 | 0.98 | 2.04 |
| debt to assets | 0.43 | 0.43 | 0.82 |
| net debt to ebitda | 21.02 | 22.72 | -7.48 |
| current ratio | 0 | 0.3 | -100.00 |
| interest coverage | 1.58 | 1.5 | 5.48 |
| income quality | 0 | 2.23 | -100.00 |
| dividend yield | None | 0.02 | NaN |
| payout ratio | None | 1.44 | NaN |
| sales general and administrative to revenue | 0 | 0.04 | -100.00 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.04 | 0.05 | -15.64 |
| capex to operating cash flow | 0 | 0.11 | -100.00 |
| capex to revenue | None | 0.05 | NaN |
| capex to depreciation | 0 | 0.13 | -100.00 |
| stock based compensation to revenue | None | 0.01 | NaN |
| graham number | 5.81 | 7.63 | -23.88 |
| roic | 0.01 | 0.01 | 5.42 |
| return on tangible assets | 0.0 | 0.01 | -41.24 |
| graham net net | -14.23 | -14.35 | 0.85 |
| working capital | 0 | -1147640000 | 100.00 |
| tangible asset value | 8323624000 | 8342684000 | -0.23 |
| net current asset value | -10747763000 | -10266506000 | -4.69 |
| invested capital | 1326090000 | 369005000 | 259.37 |
| average receivables | 698352500 | 495250500 | 41.01 |
| average payables | 298866000 | 285907000 | 4.53 |
| average inventory | -25152000 | -48871999.5 | 48.53 |
| days sales outstanding | 95.42 | 84.65 | 12.73 |
| days payables outstanding | 52.97 | 43.28 | 22.39 |
| days of inventory on hand | 0 | -8.12 | 100.00 |
| receivables turnover | 0.94 | 1.06 | -11.29 |
| payables turnover | 1.7 | 2.08 | -18.29 |
| inventory turnover | 0 | -11.08 | 100.00 |
| roe | 0.01 | 0.02 | -40.00 |
| capex per share | None | 0.05 | NaN |
ROE: Return on Equity (ROE) decreased to 0.01 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of -40.00%. Suggesting that the company has not been generating high returns for its shareholders.
Current Ratio: Current Ratio decreased to 0.00 on 2024-09-30 Q3 from 0.30 on 2024-06-30 Q2, representing a change of -100.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 46.67 on 2024-09-30 Q3 from 23.43 on 2024-06-30 Q2, representing a change of 99.21%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 1.00 on 2024-09-30 Q3 from 0.98 on 2024-06-30 Q2, representing a change of 2.04%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-01 05:30:00
HMS Networks AB (publ) (“HMS”) has today completed the previously announced acquisition of 100 percent of the shares in PEAK-System Technik GmbH (“PEAK-System”), a well-established German provider of industrial communication solutions.
Sentiment: Positive
Publish Date: 2024-10-25 13:26:04
Healthpeak Properties, Inc. (NYSE:DOC ) Q3 2024 Earnings Conference Call October 25, 2024 10:00 AM ET Company Participants Andrew Johns - Senior Vice President, IR Scott Brinker - President and CEO Peter Scott - Chief Financial Officer Scott Bohn - Chief Development Officer & Head of Lab Tom Klaritch - Chief Operating Officer Conference Call Participants Nick Yulico - Scotiabank Joshua Dennerlein - Bank of America Austin Wurschmidt - KeyBanc Capital Markets Juan Sanabria - BMO Capital Markets John Kilichowski - Wells Fargo Rich Anderson - Wedbush Michael Griffin - Citi Group Michael Carroll - RBC Capital Markets Derrick Metzler - Morgan Stanley Wes Golladay - Baird John Pawlowski - Green Street Jim Kammert - Evercore Mike Mueller - JPMorgan Operator Good morning. And welcome to the Healthpeak Properties, Inc.'s Third Quarter Conference Call.
Sentiment: Positive
Publish Date: 2024-10-01 08:35:00
HMS Networks AB (publ) (“HMS”), a global provider of industrial information and communication technology, has today entered into a binding agreement with DOGAWIST-Investment GmbH to acquire 100% of the shares in PEAK-System Technik GmbH (“PEAK-System”), a well-established German provider of industrial communication solutions.
Sentiment: Positive
Publish Date: 2024-09-25 07:00:00
The margin of safety, introduced by Benjamin Graham, emphasizes diversification to protect against volatility and human errors, enhancing the probability of profitable outcomes. Healthpeak Properties, Plymouth Industrial REIT, and Realty Income are highlighted as REITs with a significant margin of safety, each rated as a Buy. Healthpeak Properties benefits from a merger, strong earnings, and a diversified healthcare portfolio, trading at a discount with a 5.45% dividend yield.
Sentiment: Positive
Publish Date: 2024-08-30 15:01:21
High demand for lab assets and rising senior citizens' healthcare spending are likely to support DOC's performance.
Sentiment: Neutral
Publish Date: 2024-08-28 03:30:45
Healthpeak Properties, Lamar Advertising and Cousins Properties have been highlighted in this Industry Outlook article.
Sentiment: Positive
Publish Date: 2024-08-27 12:01:13
The Zacks REIT and Equity Trust - Other industry players such as DOC, LAMR and CUZ are likely to benefit from healthy fundamentals and improving demand.
Sentiment: Negative
Publish Date: 2024-08-25 13:13:46
24/7 Wall St. Insights Despite the massive market rally, some companies now trade near their all-time lows.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
